يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"Im S.-A."', وقت الاستعلام: 0.91s تنقيح النتائج
  1. 1
    دورية أكاديمية
    37OSubgroup analysis of IMpassion130: Atezolizumab + nab-paclitaxel (nab-P) in patients (pts) with advanced triple-negative breast cancer (TNBC) in Asian countries.

    المؤلفون: Iwata, H1 (AUTHOR), Im, S-A2 (AUTHOR), Sohn, J3 (AUTHOR), Jung, K H4 (AUTHOR), Im, Y-H5 (AUTHOR), Lee, K S6 (AUTHOR), Inoue, K7 (AUTHOR), Tamura, K8 (AUTHOR), Wong, A9 (AUTHOR), Emens, L A10 (AUTHOR), Barrios, C H11 (AUTHOR), Adams, S12 (AUTHOR), Schneeweiss, A13 (AUTHOR), Diéras, V14 (AUTHOR), Winer, E P15 (AUTHOR), Chui, S Y16 (AUTHOR), Henschel, V17 (AUTHOR), Rugo, H S18 (AUTHOR), Loi, S19 (AUTHOR), Schmid, P20 (AUTHOR)

    المصدر: Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.

    مصطلحات موضوعية: *TRIPLE-negative breast cancer, *RESEARCH grants, *BREAST cancer research, *PART-time employment, *STOCK options

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    39OPooled analysis of efficacy and safety in Asian patients (pts) in the MONALEESA-2, MONALEESA-3, and MONALEESA-7 trials of ribociclib (RIB) plus endocrine therapy (ET).

    المؤلفون: Im, S-A1 (AUTHOR), Yap, Y-S2 (AUTHOR), Sohn, J3 (AUTHOR), Lee, K S4 (AUTHOR), Jung, K H5 (AUTHOR), Tseng, L M6 (AUTHOR), Lee, S C7 (AUTHOR), Babu, K G8 (AUTHOR), Park, Y H9 (AUTHOR), Gounaris, I10 (AUTHOR), Sondhi, M11 (AUTHOR), Ridolfi, A12 (AUTHOR), Zarate, J P11 (AUTHOR), Lu, Y-S13 (AUTHOR)

    المصدر: Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.

    مصطلحات موضوعية: *HORMONE receptor positive breast cancer, *PATIENT safety, *HORMONE therapy, *EPIDERMAL growth factor, *PART-time employment, *RESEARCH grants

    الشركة/الكيان: PFIZER Inc. 001326495 PFE

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    35TiPRibociclib plus goserelin with hormonal therapy versus physician choice chemotherapy in pre-/perimenopausal patients with HR+, HER2– inoperable locally advanced breast cancer (ABC): RIGHT choice study.

    المؤلفون: Lu, Y-S1 (AUTHOR), Malwinder, S S2 (AUTHOR), Azim, H3 (AUTHOR), Eralp, Y4 (AUTHOR), Im, S-A5 (AUTHOR), Yap, Y S6 (AUTHOR), Alfaro, T Delgar7 (AUTHOR), Gao, M7 (AUTHOR), Saghir, N S El8 (AUTHOR)

    المصدر: Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.

    مصطلحات موضوعية: *HORMONE receptor positive breast cancer, *HORMONE therapy, *EPIDERMAL growth factor, *EXPERT evidence, *BREAST cancer, *RESEARCH grants

    الشركة/الكيان: PFIZER Inc. 001326495 PFE

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    413PDPhase I clinical and translational evaluation of AZD6738 in combination with durvalumab in patients (pts) with lung or head and neck carcinoma.

    المؤلفون: Krebs, M1 (AUTHOR), Lopez, J2 (AUTHOR), El-Khoueiry, A3 (AUTHOR), Bang, Y-J4 (AUTHOR), Postel-Vinay, S5 (AUTHOR), Abidah, W6 (AUTHOR), Im, S-A7 (AUTHOR), Khoja, L T8 (AUTHOR), Standifer, N9 (AUTHOR), Jones, G N10 (AUTHOR)

    المصدر: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.

    مصطلحات موضوعية: *LUNGS, *NECK, *CARCINOMA

    النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    330PTamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) with ribociclib (RIB) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): MONALEESA-7 subgroup analysis.

    المؤلفون: Bardia, A1 (AUTHOR), Campos-Gomez, S2 (AUTHOR), Hurvitz, S A3 (AUTHOR), Lu, Y-S4 (AUTHOR), Im, S-A5 (AUTHOR), Franke, F6 (AUTHOR), Chow, L7 (AUTHOR), Wheatley-Price, P8 (AUTHOR), Cruz, F Melo9 (AUTHOR), Alam, J10 (AUTHOR)

    المصدر: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.

    مصطلحات موضوعية: *HORMONE receptor positive breast cancer, *AROMATASE inhibitors, *BREAST cancer

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث